Investigation of factors affecting patients' preference of biologics treatment modes with rheumatoid arthritis

Investigation of factors affecting patients' preference of biologics treatment modes with rheumatoid arthritis - Investigation of factors affecting patients' preference of biologics treatment modes with rheumatoid arthritis

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000042203

Enrollment

400

Registered

2020-10-22

Start date

2020-10-23

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

rheumatoid arthritis

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: *Patients with rheumatoid arthritis aged over 20 years. *Patients who regularly visit the hospital for the treatment of rheumatoid arthritis (At least once in 3 months). *Patients who consented via the web to participate in the present research.

Exclusion criteria

Exclusion criteria: No specific criteria

Design outcomes

Primary

Measure	Time frame
Factors affecting the preference of treatment modes of rheumatoid arthritis patients using biologic disease-modifying antirheumatic drugs.	—

Secondary

Measure	Time frame
Presence or absence of a gap from the current treatment modes. Factors which desire to change the treatment modes in the future.	—

Countries

Japan

Contacts

Public ContactKitahara Yuriko

QLife Co., Ltd. Medical Solution

y-kitahara@qlife.co.jp03-6860-5020

Outcome results